US Patent Issued to Regeneron Pharmaceuticals on Aug. 25 for "Rifamycin analogs and antibody-drug conjugates thereof" (New York, Pennsylvania Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,881, issued on Aug. 25, was assigned to Regeneron Pharmaceuticals Inc..

"Rifamycin analogs and antibody-drug conjugates thereof" was invented by Thomas Nittoli (Orangeburg, N.Y.), Seungyong Sean Choi (Bristol, Pa.) and Mrinmoy Saha (Bristol, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to rifamycin analog compounds, intermediates and precursors thereof, and pharmaceutical compositions capable of inhibiting bacterial growth (e.g., S. aureus growth) and treating bacterial infections (e.g., S. aureus infections). The disclosure further relates to antibody-drug conjugates of rifamycin analog compounds and antibodies, for exa...